Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Bohnsack

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
RMD Open|July 16, 2020
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexateDaniel J Lovell, Hermine I Brunner, Andreas O Reiff, et al.
American Journal of Human Genetics|October 22, 2013
Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiencyKarin Chen, Emily M Coonrod, Attila Kumánovics, et al.
Arthritis and Rheumatism|September 29, 2011
Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitopeSampath Prahalad, Susan D Thompson, Karen N Conneely, et al.
Rheumatology (Oxford, England)|January 20, 2024
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registryDaniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, et al.
Arthritis and Rheumatism|February 23, 2012
Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13Susan D Thompson, Miranda C Marion, Marc Sudman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2017
Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility LociLaura A McIntosh, Miranda C Marion, Marc Sudman, et al.
Arthritis and Rheumatism|March 2, 2013
Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic lociSampath Prahalad, Karen N Conneely, Yunxuan Jiang, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2018
Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid ArthritisAnne Hinks, Miranda C Marion, Joanna Cobb, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
RMD Open|July 16, 2020
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexateDaniel J Lovell, Hermine I Brunner, Andreas O Reiff, et al.
American Journal of Human Genetics|October 22, 2013
Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiencyKarin Chen, Emily M Coonrod, Attila Kumánovics, et al.
Arthritis and Rheumatism|September 29, 2011
Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitopeSampath Prahalad, Susan D Thompson, Karen N Conneely, et al.
Rheumatology (Oxford, England)|January 20, 2024
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registryDaniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, et al.
Arthritis and Rheumatism|February 23, 2012
Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13Susan D Thompson, Miranda C Marion, Marc Sudman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2017
Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility LociLaura A McIntosh, Miranda C Marion, Marc Sudman, et al.
Arthritis and Rheumatism|March 2, 2013
Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic lociSampath Prahalad, Karen N Conneely, Yunxuan Jiang, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2018
Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid ArthritisAnne Hinks, Miranda C Marion, Joanna Cobb, et al.
Pageof 6